• Publications
  • Influence
Maintenance treatment with antipsychotic drugs for schizophrenia.
BACKGROUND The symptoms and signs of schizophrenia have been firmly linked to high levels of dopamine in specific areas of the brain (limbic system). Antipsychotic drugs block the transmission ofExpand
  • 168
  • 9
Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses.
IMPORTANCE There is debate about the effectiveness of psychiatric treatments and whether pharmacotherapy or psychotherapy should be primarily used. OBJECTIVES To perform a systematic overview onExpand
  • 186
  • 5
  • PDF
Benzodiazepines for schizophrenia.
BACKGROUND Because of the high number of people with schizophrenia not responding adequately to monotherapy with antipsychotic agents, the evidence regarding the efficacy and safety of additionalExpand
  • 79
  • 2
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia.
BACKGROUND Antipsychotic drugs are the core treatment for schizophrenia. Treatment guidelines state that there is no difference in efficacy between antipsychotic compounds, however, low-potencyExpand
  • 30
  • 1
Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia.
BACKGROUND Antipsychotic drugs are the core treatment for schizophrenia. Treatment guidelines state that there is no difference in efficacy between antipsychotic drugs, however, low-potencyExpand
  • 6
  • 1
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
BACKGROUND Haloperidol is worldwide one of the most frequently used antipsychotic drugs with a very high market share. Previous narrative, unsystematic reviews found no differences in terms ofExpand
  • 39
Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia.
BACKGROUND Antipsychotic drugs are the core treatment for schizophrenia. Treatment guidelines state that there is no difference in efficacy between any other antipsychotic compounds, however,Expand
  • 22
Fluphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia.
BACKGROUND Antipsychotic drugs are the core treatment for schizophrenia. Treatment guidelines state that there is no difference in efficacy between any other antipsychotic compounds, however,Expand
  • 17
Subjective sleep and cognitive complaints in 65 year old subjects: A significant association. The PROOF cohort
ObjectiveThe prevalence of subjective sleep and cognitive complaints increases with age. The purpose of this study was to investigate the link between subjective cognitive and sleep complaints in aExpand
  • 17
Are all first-generation antipsychotics equally effective in treating schizophrenia? A meta-analysis of randomised, haloperidol-controlled trials
Abstract Objectives: Narrative, unsystematic reviews revealed no differences in efficacy between the various first-generation antipsychotics (FGAs) resulting in the psychopharmacological assumptionExpand
  • 4